Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-07-01 Sale |
2024-07-01 4:38 pm |
ALUMIS INC. | ALMS | Goldstein David M Chief Scientific Officer |
216,897 | $0 | $0 | 519,065 (Indirect Direct) |
View |
| 2020-08-10 Sale |
2020-08-12 8:01 pm |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $88.61 | $531,665 | 44,699 (Direct) |
View |
| 2020-05-07 Sale |
2020-05-08 8:05 pm |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $60.16 | $360,941 | 33,415 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-18 Option Award |
2025-02-20 6:30 pm |
N/A 2035-02-17 |
ALUMIS INC. | ALMS | Goldstein David M Chief Scientific Officer |
180,000 | $0 | 396,897 (Direct) |
View |
| 2024-07-01 Option Award |
2024-07-01 4:38 pm |
N/A 2032-01-26 |
ALUMIS INC. | ALMS | Goldstein David M Chief Scientific Officer |
732,968 | $0 | 519,065 (Direct) |
View |
Ownership |
2024-06-27 4:05 pm |
N/A N/A |
ALUMIS INC. | ALMS | Goldstein David M Chief Scientific Officer |
0 | $0 | 732,968 (Indirect) |
View |
| 2020-09-28 Equity Swap |
2020-09-28 5:08 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
31,826 | $100 | 0 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
3,553 | $3.1794 | 44,699 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 8:01 pm |
N/A 2023-10-23 |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $0 | 44,699 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-12 8:01 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
2,447 | $2.9977 | 44,699 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 8:05 pm |
N/A 2023-10-23 |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $0 | 33,415 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-08 8:05 pm |
N/A N/A |
Principia Biopharma Inc. | PRNB | Goldstein David M Chief Scientific Officer |
6,000 | $2.9977 | 33,415 (Direct) |
View |